All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
| Fri 2009-02-13? to Fri 2026-02-27 |
YTD
Return |
TRR
Price |
||||
|---|---|---|---|---|---|---|
| AZN × |
+19.34%
2026-02-27 |
7.514 TRR
2026-02-27 |
||||
| AstraZeneca PLC NASDAQ Common Stock | ||||||
| Fri 2009-02-13? to Fri 2026-02-27 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| AZN × |
+651.44%
+12.57%/yr |
+11.30%/yr
(R2=0.960) |
||||
| AstraZeneca PLC NASDAQ Common Stock | ||||||
| Fri 2009-02-13? to Fri 2026-02-27 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| AZN × |
$10,000.00
2009-02-13 |
$75,144.20
2026-02-27 |
||||
| AstraZeneca PLC NASDAQ Common Stock | ||||||
| Year | AZN |
|---|---|
| 2026 (YTD) | +19.34% |
| 2025 | +34.35% |
| 2024 | −4.17% |
| 2023 | −2.31% |
| 2022 | +13.07% |
| 2021 | +11.23% |
| 2020 | +0.37% |
| 2019 | +39.16% |
| 2018 | +16.08% |
| 2017 | +21.39% |
| 2016 | −14.57% |
| 2015 | +3.24% |
| 2014 | +25.26% |
| 2013 | +29.63% |
| 2012 | +6.70% |
| 2011 | +3.20% |
| 2010 | +4.25% |
| 2009 | +23.04% |
| Fri 2009-02-13? to Fri 2026-02-27 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| AZN × | 0.00% |
−28.04%
2024-11-20 |
||||
| AstraZeneca PLC NASDAQ Common Stock | ||||||